Lisinopril

赖诺普利

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameLisinopril
Drug Alias Name苯丁酸赖脯酸lisinoprilum赖新普利利欣诺普Longes +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsFastingGenetic Predisposition to DiseaseLupus Erythematosus, Systemic +[17] 
Global Approved IndicationsHypertensionMyocardial InfarctionHeart Failure
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/29
Country/TerritoryUnited StatesNigeriaIndia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of RochesterAtnahs Pharma Uk LtdNational Cancer Institute +[7] 
Inactive CompaniesSandozIpca Laboratories LtdVanderbilt University Medical Center +[6] 
Active IndicationsLupus Erythematosus, SystemicHypertensionUrologic Diseases +[7] 
Inactive IndicationsFastingGenetic Predisposition to DiseaseMyocardial Infarction +[10] 

Other Information

ATC CodeC09AA03
Related LinksWikipediaDrugBankKEGG